Drug Profile
Isoniazid orally dissolving strip - Oak Therapeutics
Alternative Names: INH ODSLatest Information Update: 11 Dec 2021
Price :
$50
*
At a glance
- Originator Oak Therapeutics
- Class Antibacterials; Antituberculars; Carboxylic acids; Hydrazines; Isonicotinic acids; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Tuberculosis
Most Recent Events
- 28 Jun 2020 No recent reports of development identified for preclinical development in Tuberculosis in USA (PO, Fast dissolve)
- 28 Jun 2020 No recent reports of development identified for preclinical development in Tuberculosis(Prevention) in USA (PO, Fast dissolve)
- 23 Aug 2017 Oak Therapeutics plans to apply for SBIR phase II grant for isoniazid oral dissolvable strip development